Active targeted Janus nanoparticles enable anti-angiogenic drug combining chemotherapy agent to prevent postoperative hepatocellular carcinoma recurrence
- Resource Type
- Article
- Source
- In
Biomaterials February 2022 281 - Subject
- Language
- ISSN
- 0142-9612